CTKB

CTKB R&D Expense Growth

-7.45%Fiscal year

Period ending:

CTKB FY R&D Growth (YoY)%
CTKB FY R&D Growth (YoY)89.21%-21.47%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

CTKB r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Cytek Biosciences Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-7.4463%
-10.7563%
26.6596%
42.6152%
78.5%
53.3199%
0%

Compare r&d expense growth

All CTKB financial metrics · CTKB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.